KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Equity Ratio (2018 - 2021)

BioNTech SE (BNTX) posted Equity Ratio of 0.75 for Q4 2021, up 26.98% on a QoQ basis from 0.59 in Q4 2020, and up 26.98% year-over-year from 0.59 in Q4 2020.

BioNTech SE (BNTX) has 4 years of Equity Ratio data on file, last reported at 0.75 in Q4 2021.

  • In Q4 2021, Equity Ratio rose 26.98% year-over-year to 0.75; the TTM figure through Dec 2021 stood at 0.75 (up 26.98% YoY), while the FY2021 annual figure was 0.75, up 26.98% from the prior year.
  • Equity Ratio advanced to 0.75 in Q4 2021, from 0.59 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.75 in Q4 2021 and bottomed at 0.41 in Q4 2018.
  • A 4-year average of 0.59 and a median of 0.61 in 2019 frame the typical range for Equity Ratio.
  • Annual changes were most pronounced in 2019 — Equity Ratio surged 51.31% — and 2020, when it fell 4.37%.
  • Year by year, Equity Ratio stood at 0.41 in 2018, then jumped by 51.31% to 0.62 in 2019, then fell by 4.37% to 0.59 in 2020, then rose by 26.98% to 0.75 in 2021.
  • The last three Equity Ratio figures came in at 0.75 (Q4 2021), 0.59 (Q4 2020), and 0.62 (Q4 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 BioNTech SE 27.66 Bn 7.53 Bn 668.28 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2021 0.75
Dec 31, 2020 0.59
Dec 31, 2019 0.62
Dec 31, 2018 0.41